Not sure if anyone posted already but this was posted on the Fujifilm Healthcare Facebook page about iPSC
https://bioinformant.com/human-induced-pluripotent-stem-cell-hipsc-derived-tissues/
Small piece about CYP..
iPSCtechnology has made significant contributions to the biologists’ toolbox andwill continue to advance the frontiers of iPS cell research. Recently, CynataTherapeutics (ASX:CYP) commenced the world’s first clinical trial involvingan allogeneic iPSC-derived therapeutic product, which it derived from CDI’siPSCs. Similarly, many researches are investigating methods to enhance thefunctionality of terminally differentiated cells types.
Going forward..., page-1026
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |